Abstract
related to specific long-chain n3 fatty acids into strategies for improved cardiovascular health in clinical practice and public health settings. After the conference, the speakers convened to summarize the gaps in evidence, especially in the area of risk reduction by n3in primary versus secondary coronary heart disease. The summary of these discussions, suggestions for future research, and recommendations based on current evidence can be found in the Conclusions and Recommendations article, which appears in this supplement.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
